歐 聰億

Medicine & Life Sciences

1. Bacteremia 100%
2. Taiwan 81%
3. Infections 70%
4. Lemierre Syndrome 63%
5. Cross Infection 57%
6. Acinetobacter baumannii 56%
7. Vancomycin-Resistant Enterococci 51%
8. Tigecycline 41%
9. Urinary Tract Infections 40%
10. Blood Culture 40%
11. Sepsis 37%
12. Delftia acidovorans 36%
13. Critical Care 35%
14. Emphysematous Cholecystitis 35%
15. Intensive Care Units 34%
16. Colistin 34%
17. Achromobacter denitrificans 33%
18. Vibrio cholerae non-O1 33%
19. Chryseobacterium 32%
20. Pneumonia 31%
21. Candidemia 30%
22. Zygomycosis 30%
23. Trichosporon 29%
24. Micafungin 29%
25. Bacteria 28%
26. Echinocandins 27%
27. Urinary Catheterization 27%
28. Caspofungin 27%
29. Fosfomycin 27%
30. Intraabdominal Infections 26%
31. Aseptic Meningitis 26%
32. Corynebacterium 26%
33. Klebsiella pneumoniae 26%
34. Enterococcus faecium 25%
35. Cryptococcosis 25%
36. Leptospirosis 25%
37. Liver Abscess 25%
38. Microbial Drug Resistance 25%
39. Single-Chain Antibodies 25%
40. Mycoses 25%
41. Brain Abscess 25%
42. Cryptococcus neoformans 24%
43. Clostridium Infections 24%
44. Mortality 24%
45. Pneumocystis Pneumonia 24%
46. Anti-Bacterial Agents 24%
47. Meropenem 24%
48. Disinfectants 24%
49. Plasma Exchange 23%